huntington's disease

LoQus23 Therapeutics raises £35m to advance therapy for Huntington’s disease

OutSourcing-Pharma.com - 03 Oct 2024
LoQus23 Therapeutics raises £35m to advance therapy for Huntington’s disease ...

Neurophysiological hallmarks of Huntington’s disease progression: an EEG and fMRI connectivity study

Frontiers - 25 Jun 2024
Neurophysiological hallmarks of Huntington’s disease progression: an EEG and fMRI connectivity study ...

Huntington Disease Gene Therapy Nets RMAT Designation

CGTLive™ - 24 Jun 2024
Huntington Disease Gene Therapy Nets RMAT Designation ...

Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches

Frontiers - 26 Jun 2024
Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches ...

Predictive Model Accurately Tracks Alzheimer's Disease Progression

TechTarget - 02 Feb 2024
Predictive Model Accurately Tracks Alzheimer's Disease Progression ...

Investors still aren’t sold on UniQure’s gene therapy for Huntington’s

BioPharma Dive - 19 Dec 2023
Investors still aren’t sold on UniQure’s gene therapy for Huntington’s ...

New Survey Methods to Measure Quality of Life in Huntington’s Disease Patients

Michigan Medicine - 17 Oct 2016
New Survey Methods to Measure Quality of Life in Huntington’s Disease Patients ...

Huntingtin CAG repeat size variations below the Huntington’s disease threshold: associations with depression, anxiety and basal ganglia structure

Nature.com - 21 Nov 2024
Huntingtin CAG repeat size variations below the Huntington’s disease threshold: associations with depression, anxiety and basal ganglia structure ...

A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington’s Disease

Frontiers - 30 Jun 2024
A Multi-Study Model-Based Evaluation of the Sequence of Imaging and Clinical Biomarker Changes in Huntington’s Disease ...

Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities | Acta Pharmacologica Sinica

Nature.com - 05 Apr 2018
Proteostasis in Huntington's disease: disease mechanisms and therapeutic opportunities | Acta Pharmacologica Sinica ...

Strategies to Investigate Ubiquitination in Huntington's Disease

Frontiers - 27 Jun 2024
Strategies to Investigate Ubiquitination in Huntington's Disease ...

Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease

Frontiers - 16 Feb 2024
Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease ...

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility

Frontiers - 05 Feb 2024
Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility ...

Working Memory-Related Effective Connectivity in Huntington’s Disease Patients

Frontiers - 06 Feb 2024
Working Memory-Related Effective Connectivity in Huntington’s Disease Patients ...

De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease

Frontiers - 05 Feb 2024
De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease ...

Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease

Frontiers - 26 Jun 2024
Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease ...